EMN Stock Down -25% after 5-Day Loss Streak
Eastman Chemical (EMN) stock hit day 5 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -25% return. The company has lost about $1.7 Bil in value over the last 5 days, with its current market capitalization at about $6.8 Bil. The stock remains 34.3% below its value at the end of 2024. This compares with year-to-date returns of 6.1% for the S&P 500.
EMN specialty materials company offering additives, functional products, fungicides, plant growth regulators, advanced copolyesters, biopolymers, cellulose esters, PVB sheets, and protective films globally. Is this drop a warning sign or a setup for rebound? Deep dive with Buy or Sell EMN.
Comparing EMN Stock Returns With The S&P 500
The following table summarizes the return for EMN stock vs. the S&P 500 index over different periods, including the current streak:
- Rio Tinto’s Next Chapter: Growth, Guidance And Global Shifts
- Forget Timing the Bottom: Earn 10% While You Wait for BKNG on Sale
- What Could Send Micron Technology Stock Soaring
- Why U.S. Stocks Aren’t Crashing With Iran War
- Can Eli Lilly Stock Withstand These Pressures?
- Cash Rich, Low Price – Docusign Stock to Break Out?
| Return Period | EMN | S&P 500 |
|---|---|---|
| 1D | -19.0% | -1.6% |
| 5D (Current Streak) | -24.9% | -2.4% |
| 1M (21D) | -26.4% | 0.2% |
| 3M (63D) | -22.0% | 11.3% |
| YTD 2025 | -34.3% | 6.1% |
| 2024 | 5.1% | 23.3% |
| 2023 | 14.7% | 24.2% |
| 2022 | -30.4% | -19.4% |
What is the point? Sustained weakness can be more than noise. It often signals shifting sentiment or deeper concerns. A multi-day losing streak may warn of further downside, or present an opportunity to buy if fundamentals are intact. Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: EMN Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 13 S&P constituents with 3 days or more of consecutive gains and 188 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 1 | 89 |
| 4D | 10 | 33 |
| 5D | 2 | 49 |
| 6D | 0 | 4 |
| 7D or more | 0 | 13 |
| Total >=3 D | 13 | 188 |
Key Financials for Eastman Chemical (EMN)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $9.2 Bil | $9.4 Bil |
| Operating Income | $1.1 Bil | $1.4 Bil |
| Net Income | $894.0 Mil | $905.0 Mil |
Last 2 Fiscal Quarters:
| Metric | 2024 FQ4 | 2025 FQ1 |
|---|---|---|
| Revenues | $2.2 Bil | $2.3 Bil |
| Operating Income | $378.0 Mil | $318.0 Mil |
| Net Income | $330.0 Mil | $182.0 Mil |
The losing streak EMN stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.